CF
RVLP

Cantor Fitzgerald’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Cantor Fitzgerald’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,181
Closed -$1.92K – 620
2023
Q3 		$1.92K Buy
+22,181
New +$6.39K ﹤0.01% 540

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Cantor Fitzgerald's RVLP Position: Q4 2023 in Review

Cantor Fitzgerald sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 22,181 shares — an estimated $1.92K sold.

Cantor Fitzgerald first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $1.92K in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Cantor Fitzgerald reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 22,181 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $1.92K.
  • Cantor Fitzgerald first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • Cantor Fitzgerald's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.92K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.